These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16039)

  • 1. A method for evaluating anxiolytic sedatives.
    Wang RI; Wiesen RL; Stockdale S; Hieb E
    J Clin Pharmacol; 1977; 17(5-6):269-75. PubMed ID: 16039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL; Parmley LF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brief anxiety rating scale in evaluating anxiolytics.
    Wang RI; Wiesen RL; Treul S; Stockdale S
    J Clin Pharmacol; 1976; 16(2-3):99-105. PubMed ID: 3521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
    Lipman R; Vanov SK; Richards DJ
    Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
    [No Abstract]   [Full Text] [Related]  

  • 7. A study in the management of anxiety with lorazepam.
    Ellison RJ; Cancellaro LA
    J Clin Pharmacol; 1978 Apr; 18(4):210-9. PubMed ID: 24646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorazepam, a new benzodiazepine derivative, in the treatment of anxiety: a double-blind clinical evaluation.
    McCurdy L
    Am J Psychiatry; 1979 Feb; 136(2):187-90. PubMed ID: 32776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
    Cohn JB; Wilcox CS
    Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive design in evaluating anxiolytic agents.
    Uhlenhuth EH; Turner DA; Purchatzke G; Gift T; Chassan J
    Psychopharmacology (Berl); 1977 Mar; 52(1):79-85. PubMed ID: 15297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 13. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
    Kasich AM
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of suriclone, lorazepam and placebo in anxiety disorder.
    de Jonghe F; Swinkels J; Tuynman-Qua H; Jonkers F
    Pharmacopsychiatry; 1989 Nov; 22(6):266-71. PubMed ID: 2575766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative clinical study for the evaluation of antianxiety agents, (lorazepam, diazepam and placebo), in neurosis.
    Itoh H; Ohtsuka N; Kamishima K; Kaizawa S; Miura S
    Folia Psychiatr Neurol Jpn; 1977; 31(1):25-35. PubMed ID: 16815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison between nitrazepam, lorazepam, lormetazepam and placebo as preoperative night sedatives.
    Sanders LD; Yeomans WA; Rees J; Rosen M; Robinson JO
    Eur J Anaesthesiol; 1988 Nov; 5(6):377-83. PubMed ID: 2907315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.